- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapse and / or Refractory Myeloma
Total 37222 results
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic LeukemiaUnited Kingdom, Spain, France, Australia
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
Memorial Sloan Kettering Cancer CenterRecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory | Relapsed Acute Myeloid LeukemiaUnited States
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.TerminatedAcute Myeloid Leukemia | Acute Leukemia | Acute Leukemia in Relapse | Relapsed or Refractory Acute LeukemiaChina
-
Novartis PharmaceuticalsCompletedRefractory Multiple Myeloma | Multiple Myeloma in Relapse | Relapsed and Bortezomib Refractory Multiple MyelomaUnited States
-
NextCure, Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Chronic Myelomonocytic Leukemia | Relapsed or Refractory Myelodysplastic SyndromeUnited States
-
Shanxi Bethune HospitalAntengene CorporationRecruitingRelapsed or Refractory Acute Myeloid LeukemiaChina
-
University Hospital, ToulouseRecruitingRelapsed or Refractory Acute Myeloid LeukemiaFrance
-
Hui ZengCSPC Ouyi Pharmaceutical Co., Ltd.RecruitingRelapsed or Refractory Acute Myeloid LeukemiaChina
-
Seoul National University HospitalPharos iBio Co., Ltd.RecruitingRelapsed or Refractory Acute Myeloid LeukemiaKorea, Republic of
-
Aptose Biosciences Inc.RecruitingRelapsed or Refractory Acute Myeloid LeukemiaUnited States, Germany, Spain, Korea, Republic of, Australia, New Zealand
-
CStone PharmaceuticalsCompletedRelapsed or Refractory Acute Myeloid LeukemiaChina
-
University of PennsylvaniaTerminatedRelapsed or Refractory Acute Myeloid LeukemiaUnited States
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingAcute Lymphoblastic Leukemia, in Relapse | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Acute Lymphocytic Leukaemia RefractoryChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingTreatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)China
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRelapsed or Refractory Solid TumorsUnited States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Solid TumorsUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisInnovative Therapies For Children with Cancer ConsortiumUnknownRelapsed or Refractory Pediatric TumorFrance, Ireland, Israel, Italy, Spain
-
The University of Texas Health Science Center at...CompletedRefractory or Relapsed Solid TumorsUnited States
-
AstraZenecaTerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML)United States
-
National Research Center for Hematology, RussiaSt. Petersburg State Pavlov Medical University; Federal State Budgetary Institution...RecruitingRefractory Acute Myeloid Leukemia | Early Relapses of Acute Myeloid LeukemiaRussian Federation
-
BeBetter Med IncCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Non-Hodgkin's LymphomaChina
-
Arog Pharmaceuticals, Inc.CompletedPhase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating MutationsRelapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
Verastem, Inc.WithdrawnRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
-
University of Maryland, BaltimoreActive, not recruitingRelapsed or Refractory Acute Myeloid LeukemiaUnited States
-
Hematology department of the 920th hospitalRecruitingRefractory/Relapse Acute Myeloid LeukemiaChina
-
AmgenMerck Sharp & Dohme LLCTerminatedRelapsed or Refractory Acute Myeloid LeukemiaUnited States
-
Aibin Liang,MD,Ph.D.CARsgen Therapeutics Co., Ltd.RecruitingRelapsed and/or Refractory Multiple Myeloma | Plasma Cell Leukemia in RelapseChina
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior TherapiesUnited States
-
Merck Sharp & Dohme LLCTerminatedRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Chronic Myelomonocytic LeukemiaUnited States, Israel, Spain
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial HospitalNot yet recruitingCD19-positive Relapsed or Refractory B-cell MalignanciesChina
-
EdiGene (GuangZhou) Inc.The First Affiliated Hospital of Henan University of Science and TechnologyActive, not recruitingRelapsed or Refractory B-cell Malignancy(NHL/ALL)China
-
Samsung Medical CenterMinistry of Health, Republic of KoreaRecruitingRelapsed Pediatric AML | Refractory Pediatric AML | Relapsed Pediatric Solid Tumor | Refractory Pediatric Solid TumorKorea, Republic of
-
St. Jude Children's Research HospitalAbbVie; Gateway for Cancer Research; Karyopharm Therapeutics IncRecruitingRefractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Leukemia of Ambiguous Lineage in Relapse | Refractory Acute Leukemia of Ambiguous LineageUnited States
-
University of WashingtonAbbVieSuspendedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Mixed Phenotype Acute Leukemia | Myeloid Neoplasm | Acute Biphenotypic Leukemia | Refractory Acute Biphenotypic Leukemia | Relapsed Acute Myeloid Leukemia | Mixed Phenotype Acute Leukemia | Relapsed Acute Biphenotypic Leukemia | Relapsed... and other conditionsUnited States
-
Tarapeutics Science Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
Tarapeutics Science Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
First Affiliated Hospital of Zhejiang UniversityCSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.RecruitingMyeloid Malignancy | Relapsed/Refractory Acute Myeloid LeukaemiaChina
-
Beijing Boren HospitalRecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapse LeukemiaChina
-
TakedaCompletedRelapse and/or Refractory Multiple MyelomaPortugal
-
The Affiliated Hospital of the Chinese Academy...Chinese PLA General HospitalUnknown
-
Caribou Biosciences, Inc.Enrolling by invitationLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Hematologic Malignancy | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin's LymphomaUnited States
-
Oncopeptides ABTerminatedRelapsed and/or Relapsed-refractory Multiple MyelomaUnited States, Netherlands, Denmark, Sweden, Italy
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia (Relapsed/Refractory)China
-
Byondis B.V.Not yet recruitingRelapsed / Refractory AML | Relapsed / Refractory MDS
-
Sidney Kimmel Comprehensive Cancer Center at Johns...RecruitingRefractory and/or Relapsed Metastatic Solid TumorsUnited States
-
Merck Sharp & Dohme LLCCompletedRelapsed or Refractory Advanced Cancer